Clementia Pharmaceuticals Inc. — Form D

Clementia Pharmaceuticals Inc. of DORVAL, A8, a company, filed a Form D exempt-offering notice with the SEC on 2015-07-07. The offering totals $60.0M, of which $60.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2015-07-07
• Form: D
• Accession: 0000930413-15-003024
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $60.0M
• Amount sold: $60.0M
• Investors: 16
• Date of first sale: 2015-06-22
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-243197

Issuer

• Name: Clementia Pharmaceuticals Inc.
• CIK: 0001647320
• Entity type: Corporation
• Jurisdiction: CANADA (FEDERAL LEVEL)
• Incorporated: 2010
• Address: 1375 TRANS-CANADA HIGHWAY, DORVAL, A8, H9P 2W8
• Phone: (514) 940-3600

Officers, directors & promoters (12)

More

• CIK 1647320 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search